NIH Funding Opportunities

Subscribe to NIH Funding Opportunities feed
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 4 min 35 sec ago

Notice of Intent to Publish a Funding Opportunity Announcement for NINR Clinical Trial Planning Grant (R34- Clinical Trial Optional)

Mon, 07/23/2018 - 10:32
Notice NOT-NR-18-015 from the NIH Guide for Grants and Contracts
Categories: Science RSS Feeds

NCI Request for Information (RFI): Input on Development of an NCI Cancer Biomarker Data Aggregator

Mon, 07/23/2018 - 10:29
Notice NOT-CA-18-095 from the NIH Guide for Grants and Contracts
Categories: Science RSS Feeds

Request for Information (RFI): Strategies for Advancing Sepsis Research Supported by NIGMS

Mon, 07/23/2018 - 10:14
Notice NOT-GM-18-039 from the NIH Guide for Grants and Contracts
Categories: Science RSS Feeds

Notice of Change of Key Dates to RFA-HL-18-023 "Stimulating Access to Research in Residency (StARR) (R38)"

Mon, 07/23/2018 - 09:22
Notice NOT-HL-18-639 from the NIH Guide for Grants and Contracts
Categories: Science RSS Feeds

Soliciting Feedback on the BRAIN Initiative

Mon, 07/23/2018 - 09:06
Notice NOT-NS-18-075 from the NIH Guide for Grants and Contracts
Categories: Science RSS Feeds

Genome Sequencing Center for the Gabriella Miller Kids First Pediatric Research Program (U24 Clinical Trial Not Allowed)

Mon, 07/23/2018 - 08:46
Funding Opportunity RFA-RM-18-030 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to establish one or two centers that can rapidly generate high quality whole genome sequence and variant data from a large number of human specimens representing two types of pediatric conditions - childhood cancers and structural birth defects. All sequence data generated under this FOA will be re-processed and harmonized by the Gabriella Miller Kids First Pediatric Data Resource Center (Kids First DRC), which is also charged with building a public-facing, web-based portal that will allow researchers to search, access, aggregate, analyze, and share annotated genomic sequence, variant, and phenotypic datasets. Together these resources will promote comprehensive and cross-cutting research and collaboration within the pediatric research community.
Categories: Science RSS Feeds

Notice of Additional Guidance for Alzheimer's Clinical Trials Consortium (ACTC) Applicants

Mon, 07/23/2018 - 08:15
Notice NOT-AG-18-023 from the NIH Guide for Grants and Contracts
Categories: Science RSS Feeds

NIH/AHRQ Application Submission/Resubmission Policy

Mon, 07/23/2018 - 01:35
Notice NOT-OD-18-197 from the NIH Guide for Grants and Contracts
Categories: Science RSS Feeds

Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed)

Fri, 07/20/2018 - 10:34
Funding Opportunity RFA-RM-18-021 from the NIH Guide for Grants and Contracts. To solicit applications for pilot projects on IDG-eligible understudied proteins (non-olfactory GPCRs, protein kinases, and ion channels) in order to study them beyond what the IDGs Centers can accomplish, and to validate and demonstrate the utility of IDG reagents, data, and approaches.
Categories: Science RSS Feeds

Research Innovations for Scientific Knowledge (RISK) for Musculoskeletal Diseases (R61/R33 Clinical Trial Not Allowed)

Fri, 07/20/2018 - 10:16
Funding Opportunity RFA-AR-19-013 from the NIH Guide for Grants and Contracts. The NIAMS Research Innovation for Scientific Knowledge (RISK) for Musculoskeletal Diseases (R61/R33) initiative focuses on innovative research within the NIAMS mission by encouraging applicants to pursue unusual observations, test imaginative hypotheses, investigate creative concepts, and build ground-breaking paradigms, all of which deviate significantly from the current prevailing theories or practice. This FOA is particularly designed to encourage the submission of projects that are considered too risky, premature, controversial, or unconventional for other NIH mechanisms. This FOA intends to support disease-focused translational studies. We invite research studies aimed at understanding the mechanisms of diseases or conditions relevant to the NIAMS mission, as well as studies aimed at developing or testing diagnostics, therapeutic agents, or preventive interventions up to, but not including, first in human studies. The RISK R61/R33 FOAs are not intended to support clinical trials.
Categories: Science RSS Feeds

Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Musculoskeletal Diseases (X02 Clinical Trial Not Allowed)

Fri, 07/20/2018 - 10:16
Funding Opportunity PAR-18-865 from the NIH Guide for Grants and Contracts. The NIAMS Research Innovation for Scientific Knowledge (RISK) for Musculoskeletal Diseases initiative focuses on innovative research within the NIAMS mission by encouraging applicants to pursue unusual observations, test imaginative hypotheses, investigate creative concepts, and build ground-breaking paradigms, all of which deviate significantly from the current prevailing theories or practice. This FOA is particularly designed to encourage the submission of projects that are considered too risky, premature, controversial, or unconventional for other NIH mechanisms. This FOA intends to support disease-focused translational studies. We invite research studies aimed at understanding the mechanisms of diseases or conditions relevant to the NIAMS mission, as well as studies aimed at developing or testing diagnostics, therapeutic agents, or preventive interventions up to, but not including, first in human studies. The RISK R61/R33 FOAs are not intended to support clinical trials.
Categories: Science RSS Feeds

Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R01 - Clinical Trial Optional)

Thu, 07/19/2018 - 10:54
Funding Opportunity PA-18-863 from the NIH Guide for Grants and Contracts. The purpose of this funding announcement (FOA) issued by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) of the National Institutes of Health (NIH) is to encourage research grant applications that explore whether and how alcohol and other illicit drugs or illicitly used prescription drugs interact to contribute to unintentional injuries and poisonings and how to prevent and/or reduce simultaneous use of alcohol or drugs singly or in combination.
Categories: Science RSS Feeds

Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R03 - Clinical Trial Optional)

Thu, 07/19/2018 - 10:54
Funding Opportunity PA-18-861 from the NIH Guide for Grants and Contracts. The purpose of this funding announcement (FOA) issued by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) of the National Institutes of Health (NIH) is to encourage research grant applications that explore whether and how alcohol and other illicit drugs or illicitly used prescription drugs interact to contribute to unintentional injuries and poisonings and how to prevent and/or reduce simultaneous use of alcohol or drugs singly or in combination.
Categories: Science RSS Feeds

Pages